Valuation ADC Therapeutics SA

Stocks

Market Closed - NYSE 16:00:02 2026-10-16 EDT			5-day change	1st Jan Change
1.400 ^USD	-6.04%		-19.08%	-60.34%

10-09	ADC Therapeutics Cuts Debt, Extends Runway Ahead of Key Drug Data, RBC Says	MT
10-08	ADC Therapeutics SA announced that it expects to receive $81.81 million in funding from Redmile Group, LLC, TCG Crossover Management, LLC, Nantahala Capital Management, LLC, Bain Capital Life Sciences Investors, LLC	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	1,550	306.9	134.1	192.4	437.3	178.7	-	-
Change	-	-80.2%	-56.31%	43.49%	127.27%	-59.13%	-	-
Enterprise Value (EV)	1,092	90.22	-20.12	192.4	437.3	178.7	178.7	178.7
Change	-	-91.74%	-122.31%	1,056.12%	127.27%	-59.13%	0%	0%
P/E	-6.73x	-1.93x	-0.56x	-1.23x	-3.15x	-1.86x	-2.07x	-4.44x
PBR	9.34x	3.49x	-	-	-	-	-	-
PEG	-	0.1x	-0x	0x	0.1x	0.1x	0.2x	0.1x
Capitalization / Revenue	45.7x	1.46x	1.93x	2.72x	5.37x	2.22x	1.77x	1x
EV / Revenue	0x	0x	-0x	0x	0x	2.22x	1.77x	1x
EV / EBITDA	-	-	-	-	-	-	-	-
EV / EBIT	-0x	-0x	0x	-0x	-0x	-1.93x	-2.62x	-20.6x
EV / FCF	-	-	-	-	-	-	-	-
FCF Yield	-	-	-	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-3	-1.99	-2.94	-1.62	-1.12	-0.7525	-0.675	-0.315
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	33.92	209.9	69.56	70.84	81.36	80.55	100.9	178.6
EBITDA	-198.6	-71.98	-	-	-	-	-	-
EBIT ¹	-261.7	-123.6	-166	-130.7	-121.5	-92.71	-68.19	-8.66
Net income ¹	-230	-155.8	-240.1	-157.8	-142.6	-119.2	-119.1	-60.6
Net Debt	-458.5	-216.7	-154.2	-	-	-	-	-
Reference price ²	20.200	3.840	1.660	1.990	3.530	1.400	1.400	1.400
Nbr of stocks (in thousands)	76,754	79,934	80,781	96,690	123,877	127,668	-	-
Announcement Date	3/3/22	2/28/23	3/13/24	3/27/25	3/10/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ADC THERAPEUTICS SA	-1.86x	-	-	-	179M
WUXI APPTEC CO., LTD.	18.77x	6.69x	13.41x	1.58%	65B
LONZA GROUP AG	35.3x	6.27x	18.74x	0.92%	51.2B
ARGENX SE	27.56x	7.53x	23.83x	0.05%	51.19B
IQVIA HOLDINGS INC.	34.01x	3.32x	14.33x	-.--%	43.93B
BEONE MEDICINES AG	48.9x	5.59x	30.73x	-.--%	41.96B
REVOLUTION MEDICINES, INC.	-18.47x	189.62x	-19.51x	-.--%	38.14B
CELLTRION, INC.	28.97x	8.21x	21.25x	0.37%	33.24B
WUXI BIOLOGICS (CAYMAN) INC.	29.19x	6.17x	16.01x	-.--%	25.2B
GENMAB A/S	30.74x	5.69x	19.09x	-.--%	22.5B
Average	23.31x	26.57x	15.32x	0.32%	37.25B
Weighted average by Cap.	25.95x	25.01x	15.48x	0.44%